Genmab — Maj 2015
-
Jaja, men J&J er ikke så hurtige som genmab
-
Det er jo bare det vi har vidst hele tiden
-
bare vi lukker over 600 er jeg tilfreds
-
men jeg er også nordjyde og ædru pt.
-
og til nohope forespørgsel så er min have blevet usædvanlig flot i dag
-
Tror mange vil købe og få sælge imorgen....så det er spændende hvor højt vi når.....mit gæt 630. Og ingen opdager vi bryder igennem de 600
-
Fandt ud af det: The standard criteria for a complete response are the absence of monoclonal protein and less than 5 percent plasma cells in the bone marrow. A stringent complete response has the same criteria as a complete response, but also requires the absence of plasma cells in the bone marrow and a normal free light chain ratio, which can be determined using a free light chain assay. - Iøvrigt fandt jeg også ud af at remission og response er det samme.
-
ofa + idelalisib. Gilead har indsendt sBLA til FDA og vil ansøge i EU. http://finance.yahoo.com/news/zydelig-combination-ofatumumab-improves-progression-130000425.html
-
Gilead has filed a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration to include data from this study in the U.S. label. Gilead plans to submit a supplemental filing to the European Medicines Agency later this year.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind